InvestorsHub Logo
Followers 49
Posts 11280
Boards Moderated 0
Alias Born 06/15/2014

Re: dukesking post# 411517

Saturday, 07/01/2023 12:29:26 PM

Saturday, July 01, 2023 12:29:26 PM

Post# of 425636
Thanks for posting Duke. I was thinking about the Generics (maybe it is only one company) that are suing (I believe the lawsuit is still active and ongoing but could be wrong) Amarin for hogging API when I read this line:

"However, Vascepa’s expanded sales will severely constrain the overall supply of this API, making it difficult for other companies to launch generic versions of Vascepa. "

But I guess that might not come into play as I think the Generics are saying there were other nefarious things Amarin was doing with suppliers to shut out the Generics. Writing off of a bunch of inventory though might be something the Generics could hang their hat on saying that Amarin was buying up more inventory than they needed.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News